VII. Comparisons with Pancreastatin - PowerPoint PPT Presentation

slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
VII. Comparisons with Pancreastatin PowerPoint Presentation
Download Presentation
VII. Comparisons with Pancreastatin

play fullscreen
1 / 3
VII. Comparisons with Pancreastatin
99 Views
Download Presentation
chastity-battle
Download Presentation

VII. Comparisons with Pancreastatin

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. VII. Comparisons with Pancreastatin Porcine Pancreastatin UnlikePancreastatin The NETest is NOTincreased by pancreas, kidney or liver damage

  2. Comparisons of the NETest with CgA and Pancreastatin NETest is a highly accurate biomarker (>90% metrics) and outperforms CgA and pancreastatin SENS = sensitivity, SPEC = specificity, PPV = Positive Predictive Value, NPV = Negative Predictive Value

  3. What constitutes a clinically effective circulating biomarker? An effective circulating biomarker must exhibit three key technical attributes: The marker must be present in peripheral body fluid It must be easy to detect or quantify in assays that are both affordable and robust Its appearance must be associated as specifically as possible with a specific tumor, preferably in a quantifiable manner. Measurement of a biomarker should be accurate, reliable, reproducible and differentiate between normal and the specific disease of interest. All performance metrics should be >80% Biomarkers on a roll. Nat Biotechnol.2010, 28431